SMI Expanded

SMI Expanded handeln
1.812,08 PKT -2,01 PKT -0,11 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0019399861


Analysen zu SMI Expanded-Werten

Datum Rating Analyst
03.12.21 Novartis Underweight JP Morgan Chase & Co.
03.12.21 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
03.12.21 UBS Buy Jefferies & Company Inc.
02.12.21 Roche Neutral UBS AG
02.12.21 UBS Outperform RBC Capital Markets
02.12.21 UBS Sector Perform RBC Capital Markets
01.12.21 DocMorris Buy Baader Bank
01.12.21 DocMorris Sell UBS AG
01.12.21 UBS Buy Deutsche Bank AG
30.11.21 Givaudan Neutral JP Morgan Chase & Co.
30.11.21 Nestlé Overweight JP Morgan Chase & Co.
26.11.21 Novartis Neutral UBS AG
25.11.21 DocMorris Buy Jefferies & Company Inc.
24.11.21 Roche Neutral UBS AG
24.11.21 Roche Buy Deutsche Bank AG
24.11.21 Clariant Neutral Goldman Sachs Group Inc.
24.11.21 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
23.11.21 Zurich Insurance Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.11.21 UBS Buy Kepler Cheuvreux
22.11.21 Zurich Insurance Buy UBS AG
22.11.21 Holcim Buy UBS AG
22.11.21 Zurich Insurance Buy UBS AG
19.11.21 Holcim Buy Deutsche Bank AG
18.11.21 Nestlé Buy Goldman Sachs Group Inc.
18.11.21 Holcim Neutral JP Morgan Chase & Co.
18.11.21 Givaudan Underperform Bernstein Research
18.11.21 Holcim Buy UBS AG
18.11.21 Zurich Insurance Buy UBS AG
18.11.21 Nestlé Overweight JP Morgan Chase & Co.
17.11.21 Clariant Buy Baader Bank
16.11.21 ams-OSRAM Buy Kepler Cheuvreux
16.11.21 Holcim Neutral JP Morgan Chase & Co.
16.11.21 UBS Underweight JP Morgan Chase & Co.
12.11.21 Richemont Buy UBS AG
12.11.21 Richemont Overweight Morgan Stanley
12.11.21 Zurich Insurance Overweight Morgan Stanley
12.11.21 Richemont Outperform RBC Capital Markets
12.11.21 Holcim Outperform Credit Suisse Group
12.11.21 Zurich Insurance Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
11.11.21 Zurich Insurance Overweight Barclays Capital